OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study
Estela Pineda, Jarmanjeet Singh, Miguel Vargas Pineda, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Estela Pineda, Jarmanjeet Singh, Miguel Vargas Pineda, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Showing 7 citing articles:
Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis
Jiawen Deng, Daniel Rayner, Harikrishnaa Ba Ramaraju, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 5, pp. 578-586
Open Access | Times Cited: 23
Jiawen Deng, Daniel Rayner, Harikrishnaa Ba Ramaraju, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 5, pp. 578-586
Open Access | Times Cited: 23
Overview of the potential use of fluvoxamine for COVID-19 and long COVID
Kenji Hashimoto
Discover Mental Health (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 20
Kenji Hashimoto
Discover Mental Health (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 20
A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications
Mani Iyer Prasanth, Dhammika Leshan Wannigama, Angela M. Reiersen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Mani Iyer Prasanth, Dhammika Leshan Wannigama, Angela M. Reiersen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Antidepressants for prevention of severe COVID-19, Long COVID and outlook for other viral diseases
Udo Bonnet, Georg Juckel, Jens Kuhn
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Udo Bonnet, Georg Juckel, Jens Kuhn
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Antipsychotic use and 28-day mortality in patients hospitalized with COVID-19: A multicenter observational retrospective study
Marina Sánchez‐Rico, Alejandro Edán-Sánchez, Mark Olfson, et al.
European Neuropsychopharmacology (2023) Vol. 75, pp. 93-104
Open Access | Times Cited: 4
Marina Sánchez‐Rico, Alejandro Edán-Sánchez, Mark Olfson, et al.
European Neuropsychopharmacology (2023) Vol. 75, pp. 93-104
Open Access | Times Cited: 4
Die Bedeutung von Antidepressiva bei COVID-19 und Long-COVID – Ein Scoping-Review Update
Udo Bonnet, Georg Juckel
Fortschritte der Neurologie · Psychiatrie (2024)
Closed Access | Times Cited: 1
Udo Bonnet, Georg Juckel
Fortschritte der Neurologie · Psychiatrie (2024)
Closed Access | Times Cited: 1
Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis
Bincai Wei, Ruhao Zhang, Huatang Zeng, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 9, pp. 993-1009
Closed Access | Times Cited: 3
Bincai Wei, Ruhao Zhang, Huatang Zeng, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 9, pp. 993-1009
Closed Access | Times Cited: 3
